THURSDAY, Sept. 25, 2025 -- The first clinical practice guidelines on assessment and management of diabetes distress among adults were presented at...

FRIDAY, Sept. 19, 2025 -- Cannabis use is associated with a nearly quadrupled risk for developing type 2 diabetes, according to a study presented at...

FRIDAY, Sept. 19, 2025 -- Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes,...

FRIDAY, Sept. 19, 2025 -- Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes,...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and...

FRIDAY, Sept. 26, 2025 -- People living with type 2 diabetes experience double the risk for incident sepsis versus matched individuals without...

FRIDAY, Sept. 26, 2025 -- People living with type 2 diabetes experience double the risk for incident sepsis versus matched individuals without...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose...

MONDAY, Sept. 29, 2025 -- Two-year follow-up shows a loss of therapeutic benefit when baricitinib treatment is stopped in type 1 diabetes (T1D),...